WO2004056861A3 - Adiponectine et utilisations associees - Google Patents
Adiponectine et utilisations associees Download PDFInfo
- Publication number
- WO2004056861A3 WO2004056861A3 PCT/IB2003/006187 IB0306187W WO2004056861A3 WO 2004056861 A3 WO2004056861 A3 WO 2004056861A3 IB 0306187 W IB0306187 W IB 0306187W WO 2004056861 A3 WO2004056861 A3 WO 2004056861A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- adiponectin
- reagents
- glycoisoforms
- methods
- provides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Child & Adolescent Psychology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Obesity (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003285686A AU2003285686A1 (en) | 2002-12-23 | 2003-01-21 | Glycoisoforms of adiponectin and uses thereof |
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43614802P | 2002-12-23 | 2002-12-23 | |
US43617802P | 2002-12-23 | 2002-12-23 | |
NZ52341102 | 2002-12-23 | ||
NZ523410 | 2002-12-23 | ||
NZ52341002 | 2002-12-23 | ||
US60/436,178 | 2002-12-23 | ||
NZ523411 | 2002-12-23 | ||
US60/436,148 | 2002-12-23 | ||
PCT/NZ2003/000002 WO2003062275A1 (fr) | 2002-01-18 | 2003-01-17 | Glyco-isoformes d'adiponectine, et utilisations correspondantes |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004056861A2 WO2004056861A2 (fr) | 2004-07-08 |
WO2004056861A3 true WO2004056861A3 (fr) | 2004-09-30 |
Family
ID=32686197
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2003/006187 WO2004056861A2 (fr) | 2002-12-23 | 2003-01-21 | Adiponectine et utilisations associees |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003285686A1 (fr) |
WO (1) | WO2004056861A2 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8394992B2 (en) | 2004-07-19 | 2013-03-12 | Philera New Zealand Limited | Synthesis of triethylenetetramines |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000018392A1 (fr) | 1998-09-25 | 2000-04-06 | Glycox Corporation Limited | Fructosamine-oxydase: antagonistes et inhibiteurs |
JP4860906B2 (ja) | 2002-03-08 | 2012-01-25 | プロテミックス コーポレイション リミティド | 心疾患および/または関連心不全の予防および/または治療 |
CA2496411A1 (fr) | 2002-08-20 | 2004-03-04 | Protemix Corporation Limited | Formes posologiques et traitements s'y rapportant |
WO2006062422A1 (fr) | 2004-12-10 | 2006-06-15 | Protemix Corporation Limited | Glyponectine (adiponectine glycosylee) pour le traitement de maladies et d'etats pathologiques |
US7964557B2 (en) | 2005-03-28 | 2011-06-21 | University Of Louisville Research Foundation, Inc. | Inhibition of wet type age related macular degeneration (AMD) by adiponectin or acrp 30 |
CN103041371A (zh) * | 2012-12-31 | 2013-04-17 | 上海市内分泌代谢病研究所 | 脂联素在制备治疗老年缺血性脑卒中药物中的应用 |
WO2020201195A2 (fr) * | 2019-04-04 | 2020-10-08 | Bayer Aktiengesellschaft | Agonistes d'adiponectine |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002100427A1 (fr) * | 2001-06-07 | 2002-12-19 | Sankyo Company, Limited | Promoteur de generation de foie |
WO2003062275A1 (fr) * | 2002-01-18 | 2003-07-31 | Protemix Corporation Limited | Glyco-isoformes d'adiponectine, et utilisations correspondantes |
-
2003
- 2003-01-21 AU AU2003285686A patent/AU2003285686A1/en not_active Abandoned
- 2003-01-21 WO PCT/IB2003/006187 patent/WO2004056861A2/fr not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002100427A1 (fr) * | 2001-06-07 | 2002-12-19 | Sankyo Company, Limited | Promoteur de generation de foie |
WO2003062275A1 (fr) * | 2002-01-18 | 2003-07-31 | Protemix Corporation Limited | Glyco-isoformes d'adiponectine, et utilisations correspondantes |
Non-Patent Citations (10)
Title |
---|
BERG A H ET AL: "The adipocyte-secreted protein Acrp30 enhances hepatic insulin action", NATURE MEDICINE, NATURE PUBLISHING, CO, US, vol. 7, no. 8, August 2001 (2001-08-01), pages 947 - 953, XP002242789, ISSN: 1078-8956 * |
BERG ANDERS H ET AL: "ACRP30/adiponectin: An adipokine regulating glucose and lipid metabolism.", TRENDS IN ENDOCRINOLOGY AND METABOLISM, vol. 13, no. 2, March 2002 (2002-03-01), pages 84 - 89, XP002286670, ISSN: 1043-2760 * |
COMBS TERRY P ET AL: "Endogenous glucose production is inhibited by the adipose-derived protein Acrp30", JOURNAL OF CLINICAL INVESTIGATION, vol. 108, no. 12, December 2001 (2001-12-01), pages 1875 - 1881, XP002286669, ISSN: 0021-9738 * |
HOTTA K ET AL: "Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys", DIABETES, NEW YORK, NY, US, vol. 50, no. 5, May 2001 (2001-05-01), pages 1126 - 1133, XP002970250, ISSN: 0012-1797 * |
OKAMOTO Y ET AL: "ADIPOCYTE-DERIVED PLASMA PROTEIN, ADIPONECTIN, ADHERES TO INJURED VASCULAR WALLS", HORMONE AND METABOLIC RESEARCH, THIEME-STRATTON, STUTTGART, DE, vol. 32, February 2000 (2000-02-01), pages 47 - 50, XP000933764, ISSN: 0018-5043 * |
SATO C ET AL: "Identification and adipocyte differentiation-dependent expression of the unique disialic acid residue in an adipose tissue-specific glycoprotein, adipo Q", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 276, no. 31, 3 August 2001 (2001-08-03), pages 28849 - 28856, XP002966354, ISSN: 0021-9258 * |
SCHERER P E ET AL: "A NOVEL SERUM PROTEIN SIMILAR TO C1Q, PRODUCED EXCLUSIVELY IN ADIPOCYTES", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 270, no. 45, 1 November 1995 (1995-11-01), pages 26746 - 26749, XP000612012, ISSN: 0021-9258 * |
WANG YU ET AL: "Hydroxylation and glycosylation of the four conserved lysine residues in the collagenous domain of adiponectin. Potential role in the modulation of its insulin-sensitizing activity", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 277, no. 22, 31 May 2002 (2002-05-31), pages 19521 - 19529, XP002242790, ISSN: 0021-9258 * |
YAMAUCHI T ET AL: "The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity", NATURE MEDICINE, NATURE PUBLISHING, CO, US, vol. 7, no. 8, August 2001 (2001-08-01), pages 941 - 946, XP002242792, ISSN: 1078-8956 * |
YANG W S ET AL: "Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin.", THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM. UNITED STATES AUG 2001, vol. 86, no. 8, August 2001 (2001-08-01), pages 3815 - 3819, XP002286668, ISSN: 0021-972X * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8394992B2 (en) | 2004-07-19 | 2013-03-12 | Philera New Zealand Limited | Synthesis of triethylenetetramines |
US8912362B2 (en) | 2004-07-19 | 2014-12-16 | Philera New Zealand Limited | Synthesis of triethylenetetramines |
US9556123B2 (en) | 2004-07-19 | 2017-01-31 | Philera New Zealand Limited | Synthesis of triethylenetetramines |
Also Published As
Publication number | Publication date |
---|---|
AU2003285686A8 (en) | 2004-07-14 |
AU2003285686A1 (en) | 2004-07-14 |
WO2004056861A2 (fr) | 2004-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004011611A3 (fr) | Anticorps anti-taci et utilisations de ceux-ci | |
WO2005005679A3 (fr) | Surfaces superhydrophobes, methodes de leur construction et leurs utilisations | |
TW200608961A (en) | Methods and reagents for the treatment of metabolic disorders | |
AU2002339691A1 (en) | Agonists and antagonists of prolixin for the treatment of metabolic disorders | |
WO2003000853A3 (fr) | Essais pour agregation de proteines, et utilisations | |
WO2004020458A3 (fr) | Tests et compositions d'identification d'agents modulant l'activite d'agents de desubiquitination | |
WO2003104410A3 (fr) | Enzymes | |
WO2003078574A3 (fr) | Nouveaux marqueurs et cibles metaboliques | |
WO2004056861A3 (fr) | Adiponectine et utilisations associees | |
WO2002097060A3 (fr) | Proteines associees aux carbohydrates | |
AU2003285485A1 (en) | 5 ANDROSTEN-3Beta-OL STEROID INTERMEDIATES AND PROCESSES FOR THEIR PREPARATION | |
WO2004044165A3 (fr) | Proteines associees aux lipides | |
WO2003062391A3 (fr) | Proteines structurelle associees au cytosquelette | |
WO2004003162A3 (fr) | Enzymes | |
WO2003064468A3 (fr) | Fragment peptidique comprenant une poche de liaison au ligand du recepteur 3 des oestrogenes et utilisations associees | |
WO2003100016A3 (fr) | Molecules de modification et de maintenance de proteines | |
AU2003235630A1 (en) | Method for screening biological samples for presence of the metabolic syndrome | |
WO2003072729A3 (fr) | Enzymes | |
WO2004031364A3 (fr) | Proteines associees a la croissance, a la differenciation, et a la mort des cellules | |
AU2002339673A1 (en) | Agonists and antagonists of ryzn for the treatment of metabolic disorders | |
WO2004010139A3 (fr) | Methode d'identification de composes biologiquement actifs dotes de proprietes anti-asthmatiques, anti-allergiques et/ou d'un pouvoir immunosuppresseur | |
EP1454282A4 (fr) | Procedes et systemes permettant d'identifier des composants de reseaux biochimiques mammaliens comme etant des cibles d'agents therapeutiques | |
WO2003093439A3 (fr) | Enzymes | |
WO2004060282A3 (fr) | Utilisations du recepteur snorf207 | |
WO2003095622A3 (fr) | Proteines associees a la croissance, la differentiation et la mort cellulaires |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |